DKFZP564O0823 Antibody (C-term) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q6UWI2 |
---|
Gene ID | 25849 |
---|---|
Other Names | Prostate androgen-regulated mucin-like protein 1, PARM-1, PARM1 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | PARM1 |
---|---|
Function | May regulate TLP1 expression and telomerase activity, thus enabling certain prostatic cells to resist apoptosis. |
Cellular Location | Cell membrane; Single-pass type I membrane protein Golgi apparatus membrane; Single-pass type I membrane protein. Endosome membrane; Single-pass type I membrane protein |
Tissue Location | Widely expressed with highest levels in heart, kidney and placenta. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
DKFZP564O0823 may regulate TLP1 expression and telomerase activity, thus enabling certain prostatic cells to resist apoptosis.
References
Fladeby, C., et al. Int. J. Cancer 122(6):1229-1235(2008)Starkuviene, V., et al. Genome Res. 14 (10A), 1948-1956 (2004) Zhang, Z., et al. Protein Sci. 13(10):2819-2824(2004)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.